lumbosacral canal stenosis. Spinal stenosis, lumbar region
Conditions
Interventions
Intervention 1: Intervention group: Ketorolac injection by mesotherapy method. Intervention 2: Intervention group: Injection of methylprednisolone into trigger points.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are: completion and signing of the informed consent form, presence of pain and other clinical symptoms of lumbosacral spinal stenosis L4-L5-S1 (confirmed by paraclinical tests MRI and nerve and muscle conduction study) in the past six months and lack of response to conservative treatments, age between 35-75 years, and absence of any disease around the spine.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: diabetes mellitus, rheumatic and collagen vascular diseases, gout and lupus, nerve damage and neuropathies, brucellosis, body mass index above 41, history of spinal trauma and fracture, presence of emergency surgical criteria for the spine (red flag), bleeding disorders, inability to communicate and complete questionnaires, history of allergy and hypersensitivity reactions to the drugs used, history of significant liver, kidney, and cardiopulmonary disorders, history of injections into or around the spine in the past 3 months, pregnancy, individuals with cancer, and individuals currently using anticoagulant medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief. Timepoint: Weeks 2, 4 and 8 after the last treatment session. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional improvement. Timepoint: Weeks 2, 4 and 8 after the last treatment session. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Reza Farpoor
Shiraz University of Medical Sciences
Outcome results
None listed